has been a member of advisory boards or has consulted with Boehringer Ingelheim, Eli Lilly & Co., Medtronic, Merck, Sharp & Dohme, NovoNordisk, Pfizer, Regor, Sun Pharma and Structure Therapeutics (ShouTi, Gasherbrum)
During the COVID-19 pandemic, individuals with thyroid diseases (mostly autoimmune) showed lower adherence to the MeD, higher prevalence of overweight, and reduced physical activity compared with controls, further supporting the benefits of healthy lifestyle choices [176]
SKU : 38004
2022;377: e068882
Research indicates that stopping or interrupting obesity treatments, particularly weight-loss medications like GLP-1 drugs, frequently results in a rapid regain of lost weight
& Moldovan, L